CN Patent

CN109701030A — 聚乙二醇化小分子药物的制备方法

Assigned to Hunan Huateng Pharmaceutical Co Ltd · Expires 2019-05-03 · 7y expired

What this patent protects

本发明公开了一种聚乙二醇化小分子药物的制备方法,具体涉及到洛伐他汀的聚乙二醇修饰物的制备方法。第一步将聚乙二醇进行氧化反应得到聚乙二醇单羧酸;第二步把聚乙二醇单羧酸与洛伐他汀进行缩合反应得到目标产物,即聚乙二醇修饰的洛伐他汀化合物。洛伐他汀的聚乙二醇修饰物中含有可降解的酯键,可达到缓释效果;具有两亲性,提高洛伐他汀的水溶性,利于人体吸收,减轻洛伐他汀的刺激作用。

USPTO Abstract

本发明公开了一种聚乙二醇化小分子药物的制备方法,具体涉及到洛伐他汀的聚乙二醇修饰物的制备方法。第一步将聚乙二醇进行氧化反应得到聚乙二醇单羧酸;第二步把聚乙二醇单羧酸与洛伐他汀进行缩合反应得到目标产物,即聚乙二醇修饰的洛伐他汀化合物。洛伐他汀的聚乙二醇修饰物中含有可降解的酯键,可达到缓释效果;具有两亲性,提高洛伐他汀的水溶性,利于人体吸收,减轻洛伐他汀的刺激作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN109701030A
Jurisdiction
CN
Classification
Expires
2019-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Huateng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.